tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

AXSM Stock Latest News

Axsome Therapeutics price target raised to $195 from $190 at TD Cowen
The FlyAxsome Therapeutics price target raised to $195 from $190 at TD Cowen
5d ago
AXSM
Axsome Therapeutics management to meet with Oppenheimer
PremiumThe Fly
Axsome Therapeutics management to meet with Oppenheimer
13d ago
AXSM
Axsome Therapeutics price target raised to $219 from $212 at RBC Capital
PremiumThe Fly
Axsome Therapeutics price target raised to $219 from $212 at RBC Capital
13d ago
AXSM
Reaffirming Axsome Therapeutics as a Buy on Robust Commercial Growth and Advancing Late‑Stage Pipeline, With a Raised $260 Price Target
PremiumRatings
Reaffirming Axsome Therapeutics as a Buy on Robust Commercial Growth and Advancing Late‑Stage Pipeline, With a Raised $260 Price Target
14d ago
AXSM
Axsome Therapeutics price target raised to $260 from $200 at H.C. Wainwright
PremiumThe Fly
Axsome Therapeutics price target raised to $260 from $200 at H.C. Wainwright
14d ago
AXSM
Axsome Therapeutics price target raised to $223 from $148 at Piper Sandler
PremiumThe FlyAxsome Therapeutics price target raised to $223 from $148 at Piper Sandler
18d ago
AXSM
Axsome Therapeutics initiate FORWARD Phase 3 trial of AXS-14
Premium
The Fly
Axsome Therapeutics initiate FORWARD Phase 3 trial of AXS-14
19d ago
AXSM
Axsome Therapeutics price target raised to $209 from $157 at Baird
Premium
The Fly
Axsome Therapeutics price target raised to $209 from $157 at Baird
21d ago
AXSM
Axsome Therapeutics price target raised to $193 from $157 at Wells Fargo
PremiumThe Fly
Axsome Therapeutics price target raised to $193 from $157 at Wells Fargo
21d ago
AXSM
Axsome Therapeutics: Strong Commercial Execution and De-Risked Pipeline Support Buy Rating and Long-Term Growth
PremiumRatings
Axsome Therapeutics: Strong Commercial Execution and De-Risked Pipeline Support Buy Rating and Long-Term Growth
22d ago
AXSM
Buy Rating on Axsome Therapeutics Backed by Strong Auvelity and Sunosi Outperformance Despite Slower Symbravo Ramp
PremiumRatings
Buy Rating on Axsome Therapeutics Backed by Strong Auvelity and Sunosi Outperformance Despite Slower Symbravo Ramp
22d ago
AXSM
Axsome Therapeutics Reports Strong Preliminary 2025 Revenue Growth
PremiumCompany Announcements
Axsome Therapeutics Reports Strong Preliminary 2025 Revenue Growth
22d ago
8K
AXSM
Axsome Therapeutics reports preliminary Q4 revenue $196M, consensus $187.02M
PremiumThe FlyAxsome Therapeutics reports preliminary Q4 revenue $196M, consensus $187.02M
22d ago
AXSM
Axsome Therapeutics downgraded to Equal Weight from Overweight at Morgan Stanley
Premium
The Fly
Axsome Therapeutics downgraded to Equal Weight from Overweight at Morgan Stanley
26d ago
AXSM
Axsome Therapeutics management to meet with B. Riley
Premium
The Fly
Axsome Therapeutics management to meet with B. Riley
28d ago
AXSM
Axsome Therapeutics price target raised to $248 from $163 at UBS
PremiumThe Fly
Axsome Therapeutics price target raised to $248 from $163 at UBS
28d ago
AXSM
Axsome Therapeutics price target raised to $225 from $169 at Needham
PremiumThe Fly
Axsome Therapeutics price target raised to $225 from $169 at Needham
29d ago
AXSM
Axsome Therapeutics price target raised to $200 from $185 at H.C. Wainwright
PremiumThe Fly
Axsome Therapeutics price target raised to $200 from $185 at H.C. Wainwright
29d ago
AXSM
Top 5 Trending Stocks by Unusual Trading Volume, 1/1/26
PremiumMarket News
Top 5 Trending Stocks by Unusual Trading Volume, 1/1/26
1M ago
FG
SNV
Axsome Therapeutics price target raised to $217 from $202 at Mizuho
PremiumThe FlyAxsome Therapeutics price target raised to $217 from $202 at Mizuho
1M ago
AXSM
Axsome Therapeutics rises 19.4%
Premium
The Fly
Axsome Therapeutics rises 19.4%
1M ago
AXSM
Axsome Therapeutics: Late-Stage CNS Pipeline and Regulatory Tailwinds Support Buy Rating
Premium
Ratings
Axsome Therapeutics: Late-Stage CNS Pipeline and Regulatory Tailwinds Support Buy Rating
1M ago
AXSM

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >